Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma

Blood (2016) 128 (7): 959–970.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals